Back to Search
Start Over
Progress in Development of Targeted Therapeutic Drugs for Acute Myeloid Leukemia
- Source :
- Zhongliu Fangzhi Yanjiu, Vol 50, Iss 4, Pp 413-421 (2023)
- Publication Year :
- 2023
- Publisher :
- Magazine House of Cancer Research on Prevention and Treatment, 2023.
-
Abstract
- Targeted therapeutic drugs for acute myeloid leukemia (AML) are showing immense development, thereby laying a solid foundation for the precise treatment of AML patients. The paper reviews four types of targeted drugs that have progressed rapidly for AML treatment (by targeting genes or signaling-pathway alterations, targeting apoptosis-related pathways, targeting cell-surface antigens, and targeting immune-related substances). We look forward to the future development directions of targeted drugs, providing references for hematologists and developers of new drugs for AML.
Details
- Language :
- Chinese
- ISSN :
- 10008578
- Volume :
- 50
- Issue :
- 4
- Database :
- Directory of Open Access Journals
- Journal :
- Zhongliu Fangzhi Yanjiu
- Publication Type :
- Academic Journal
- Accession number :
- edsdoj.b7951e01e6f41baa25f3c33f60ca082
- Document Type :
- article
- Full Text :
- https://doi.org/10.3971/j.issn.1000-8578.2023.22.1056